##  [Tratamento inovador para o cancro do rim](/sobre-nos/revista-mais-vida/tratamento-inovador-para-o-cancro-do-rim) 

 
            .field_media_image-background-img {
              background-image: url('/sites/portalcuf/files/styles/16_9/public/media/image/2024-11/screenshot-2024-11-22-15.49.04.png?h=7143be3d&itok=KkOeiV02');
              @supports (background-image: url('/sites/portalcuf/files/styles/16_9_webp/public/media/image/2024-11/screenshot-2024-11-22-15.49.04.png.webp?itok=qgxBHFwd')) {
                background-image: url('/sites/portalcuf/files/styles/16_9_webp/public/media/image/2024-11/screenshot-2024-11-22-15.49.04.png.webp?itok=qgxBHFwd');
              }
            }

                        .simple-heading .content-img .background-img {
              position: relative;
              background-size: cover;
              background-position: center;
              height: 100%;
              width: 100%;
              overflow: hidden;
            }
            .simple-heading .content-img .background-img::before {
              content: " ";
              background-color: rgba(0, 162, 206, 0.05);
              display: inline-block;
              position: absolute;
              right: 0;
              top: 0;
              height: 100%;
              width: 100%;
              left: 0;
              z-index: 0;
            }
            .simple-heading .content-img .background-img::after {
              content: " ";
              display: inline-block;
              position: absolute;
              right: 0;
              top: 0;
              height: 100%;
              width: 100%;
              left: 0;
              z-index: 0;
            }

            .simple-heading .content-img .background-img.filtered:after {
              background-color: rgba(32, 57, 74, 0.3);
            }

            @media (max-width: 1024px) {
              .simple-heading .content-img {
                margin-right: 0px;
                padding-right: 0px;
                height: 100%;
              }
            }


           

 

  1. [Início](/)
2. Tratamento inovador para o cancro do rim
 
  

 # Tratamento inovador para o cancro do rim

 

 

 



 

 



A Unidade de Tumores Urológicos CUF passou a realizar uma técnica que junta a cirurgia robótica à biotecnologia no tratamento do cancro do rim – a Nefrectomia Parcial RSD – cujos resultados mostram um menor risco de complicações pós-operatórias e uma recuperação mais rápida. David Subirá, Coordenador de Urologia no Hospital CUF Tejo, conta a complexidade do caso de Maria Teresa Matias em reportagem.



 

 



Revista +VIDA 34

 [ Leia o artigo aqui](https://revista-mais-vida.cuf.pt/view/485728371/42/) 



 

 

 

 

 



 

Publicado a 28/11/2024

Download



Partilhar

- [ ![Email](https://www.cuf.pt//sites/portalcuf/files/media/icon/2019-12/bas-034.svg) ](mailto:?subject=Tratamento inovador para o cancro do rim&body=Ver no site da CUF mais sobre https://www.cuf.pt/markdownify/node/110131%3Futm_campaign%3Dcuf_social%2Bshare_ao%26utm_medium%3Dearned%2Bsocial%26utm_source%3Dmail "Email")
- [ ![Whatsapp](https://www.cuf.pt//sites/portalcuf/files/media/icon/2019-12/bas-030.svg) ](https://wa.me?text=https://www.cuf.pt/markdownify/node/110131%3Futm_campaign%3Dcuf_social%2Bshare_ao%26utm_medium%3Dearned%2Bsocial%26utm_source%3Dwhatsapp "Whatsapp")
- [ ![Facebook](https://www.cuf.pt//sites/portalcuf/files/media/icon/2019-12/bas-016.svg) ](https://www.fb.com/share.php?u=https://www.cuf.pt/markdownify/node/110131%3Futm_campaign%3Dcuf_social%2Bshare_ao%26utm_medium%3Dearned%2Bsocial%26utm_source%3Dfacebook "Facebook")
- [ ![X](https://www.cuf.pt//sites/portalcuf/files/media/icon/2026-01/x-32_0.svg) ](https://x.com/intent/tweet?url=https://www.cuf.pt/markdownify/node/110131%3Futm_campaign%3Dcuf_social%2Bshare_ao%26utm_medium%3Dearned%2Bsocial%26utm_source%3Dtwitter "X")
- [ ![Linkedin](https://www.cuf.pt//sites/portalcuf/files/media/icon/2019-12/bas-031.svg) ](http://www.linkedin.com/shareArticle?mini=true&url=https://www.cuf.pt/markdownify/node/110131%3Futm_campaign%3Dcuf_social%2Bshare_ao%26utm_medium%3Dearned%2Bsocial%26utm_source%3Dlinkedin "Linkedin")
 


 

 

 



Related Articles